People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pasteuria Bioscience, Inc. | — | Other | Seed | $3.2M | $34.9M | 2009 |
Fouad Azaam, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fouad Azaam, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Molloy | 1 | 7 |
| Kelly Smith | 1 | 5 |
| Jorg Riesmeier | 1 | 2 |
| Timothy Cockshutt | 1 | 2 |
| David N. Duncan, Ph.D. | 1 | 1 |
| Al N. Kern | 1 | 1 |
| Martijn N. Kleijwegt | 1 | 1 |
| Fouad N. Azaam, Ph.D. | 1 | 1 |
| Richard N. Molloy | 1 | 1 |
| Al Kern | 1 | 1 |
| Timothy N. Cockshutt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.